News
4317 posts · page 17 of 180
Trump Administration Pushes A.I. in Healthcare Amid Safety Concerns
The U.S. government is advancing A.I. in healthcare, sparking debates over safety and investor influence.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare may acquire Sofie Biosciences for $1 billion, enhancing its diagnostics unit.
IMA Punjab Supports Strike Against FIR Filed Over Patient Death
The Indian Medical Association in Punjab endorses a doctors' strike following an FIR against a physician after a patient's death.
Montreal AI Conference Tackles Canada's Doctor Shortage Crisis
Experts at a Montreal conference examine AI's potential to address Canada's pressing doctor shortage.
Doctor Shortage in the U.S. Poses a National Security Risk
The U.S. faces a critical doctor shortage, raising concerns over national security and healthcare capacity.
New Mexico Expands Loan Repayment to Combat Doctor Shortage
New Mexico's expanded loan repayment aims to tackle its healthcare provider shortage.
Navigating Conversations with Your Doctor on Menopause Symptoms
Discussing severe menopause symptoms with your doctor can improve management and relief.
Phone Call Error Triggers Significant Healthcare Data Breach
A mishandled doctor's appointment call resulted in a major data breach, exposing patient information.
Cedars-Sinai Guides Patients on AI Use Before Doctor Visits
Cedars-Sinai advises patients on using AI tools for better pre-visit preparation.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in First Post-IPO Quarter
Molbio Diagnostics posts Rs 52.7 crore profit in Q1, reversing a Rs 23.94 crore loss last year, driven by Truenat test-kit sales.
iOncology.ai: Indian AI Platform for Cancer Care Featured in BRICS Health Journal
iOncology.ai, an AI platform developed by AIIMS and C-DAC, gains recognition in BRICS Health Journal for its potential in transforming cancer care in emerging economies.
Waystar Considers Sale Amidst Market Challenges
Waystar explores strategic options, including a potential sale, as it navigates a challenging software market.
Trump Administration Pushes A.I. in Healthcare Amid Safety Concerns
Federal initiatives deploy A.I. for therapy and prescriptions, sparking safety worries.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion deal to acquire Sofie Biosciences, a leader in cancer scan chemicals.
Molbio Diagnostics Surges to Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics reports Rs 52.7 crore profit in Q1, rebounding from last year's loss, driven by Truenat test-kit sales.
Indian AI Platform for Cancer Care Debuts in BRICS Health Journal
iOncology.ai, an AI-driven cancer care platform, is spotlighted in the BRICS Health Journal, highlighting India's innovation in healthcare technology.
Waystar Weighs Sale Options Amid Market Downturn
Waystar is considering a sale, two years after going public, amid a market slump.
U.S. Government Pushes A.I. in Healthcare Amid Safety Concerns
The Trump administration is advancing A.I. in healthcare, sparking debate over safety and investor influence.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion acquisition of Sofie Biosciences, a leader in cancer scan chemicals.
Molbio Diagnostics Achieves Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics reports Rs 52.7 crore profit in Q1, reversing last year's loss post-IPO.
Indian AI Platform for Cancer Care Spotlighted at BRICS Summit
iOncology.ai, an AI-driven cancer care platform from India, gains recognition at the BRICS Summit, highlighting its potential in transforming healthcare.
Waystar Weighs Sale Amidst Software Sector Challenges
Waystar, a healthcare software provider, is exploring a potential sale, hiring Evercore for advisory as its market value drops.
Trump Administration Advances A.I. in Healthcare Amid Safety Concerns
Federal initiatives introduce A.I. in medical roles, sparking debates over patient safety and venture capital influence.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion deal to acquire Sofie Biosciences, enhancing its diagnostics division.